Kayyal Alex
Known title: DirectorCIK: 0002056310
Associated companies
Transaction History
| TTD | ▲ Buy | Grant | 102,655 | $0 | 8/21/2025 | View on chart |
| TTD | ▼ Sell | Other | 1,002 | $0 | 8/20/2025 | View on chart |
| TTD | ▼ Sell | Other | 1,838 | $0 | 8/20/2025 | View on chart |
| TTD | ▼ Sell | Other | 317 | $19K | 8/20/2025 | View on chart |
| TTD | ▲ Buy | Grant | 2,450 | $0 | 5/27/2025 | View on chart |
| TTD | ▲ Buy | Grant | 422 | $25K | 5/27/2025 | View on chart |
| TTD | ▲ Buy | Grant | 1,202 | $0 | 2/14/2025 | View on chart |
| TTD | ▲ Buy | Grant | 318 | $0 | 2/14/2025 | View on chart |
| TTD | ▲ Buy | Grant | 57 | $7K | 2/14/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
TTD down 77% while market rises; healthcare integration news
The Trade Desk shares have fallen 77% while the broader market has risen, leading to comparisons with other ad-tech stocks like Alphabet and AppLovin. Recent news highlights a healthcare inventory integration with OptimizeRx, which may be relevant to its advertising capabilities. Despite the significant price drop, the stock trades at a trailing P/E of 13.8, well below its 52-week high of $56.39.
TTD down 77% while market rises; healthcare integration news. The Trade Desk shares have fallen 77% while the broader market has risen, leading to comparisons with other ad-tech stocks like Alphabet and AppLovin. Recent news highlights a healthcare inventory integration with OptimizeRx, which may be relevant to its advertising capabilities. Despite the significant price drop, the stock trades at a trailing P/E of 13.8, well below its 52-week high of $56.39.